Sleep Restriction and Parental History of Hypertension
Mayo Clinic · with National Heart, Lung, and Blood Institute (NHLBI) · NCT06482814
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–35 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 44
- US sites recruiting
- 1
- Study start
- February 20, 2025
- Record last updated
- August 13, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to research the effects of partial sleep deprivation (sleep restriction) in a group of individuals whose parents have high blood pressure compared to a group of individuals whose parents have normal blood pressure.
Being studied: Partial sleep deprivation (sleep restriction); Normal sleep
Conditions: Hypertension
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Healthy adults aged 18-35 years
- Absence of any significant medical or psychiatric disease (as per the investigators' judgment)
- Nonsmoker
- Nonpregnant
- History of normal sleep duration (reported average sleep duration between 7-9 hours/night and no habitual napping)
- Hypertension status information available for both biological parents
- Ability to understand study procedures and to comply with them for the entire length of the study
- Ability to understand English and provide informed consent
Exclusion Criteria
- Age \<18 or >35 years
- Body mass index \<18.5 or ≥30 kg/m2
- Pregnant or lactating
- Unable to determine history of HTN in participant's biological parents or subject being adopted
- Use of tobacco, vaping, marijuana products or other drugs
- Excessive caffeine consumption (>400 mg/day)
- Excessive alcohol consumption (>7 drinks/week for women, >14 drinks/week for men)
- Office SBP/DBP ≥130/80 mmHg
- Daytime ambulatory SBP/DBP ≥130/80 mmHg
- Fasting glucose ≥126 mg/dl
- Glomerular filtration rate \<60 mL/min/BSA
- History of significant medical or psychiatric disorders (as per the investigators' judgment)
- Regular use of prescription medications other than contraceptives
- Use of melatonin supplements or any other over-the-counter sleep aid
- Moderate-to-severe sleep disordered breathing (apnea/hypopnea index, AHI ≥15) or mild sleep disordered breathing (AHI 5-15) with daytime sleepiness (Epworth Sleepiness Scale >10)
- Moderate-to-severe insomnia (Insomnia Severity Index >14)
- Restless leg syndrome (as per the Cambridge-Hopkins questionnaire)
- Excessive daytime sleepiness (Epworth Sleepiness Scale >15)
- Extreme chronotype (Morningness-Eveningness Questionnaire >69 or \<31)
- Night shift work
- Ongoing participation in other research studies (as per the investigators' judgment)
- Any other medical, geographic, or social factor making study participation impractical
- Not English-speaking and/or inability to provide informed consent
- Exclusionary for blood draws: hemoglobin \<11.6 g/dL in women / \<13.2 g/dL in men; participants with measured hemoglobin levels below these thresholds will be allowed to continue participate in study tests and procedures not involving blood draws.
Recruiting US locations
Mayo Clinic in Rochester
Rochester, MN 55905
Site contact: Naima Covassin
Study contacts (from the official record)
- Sabah Munir · (507)255-0151 · Munir.Sabah@mayo.edu
Similar studies in Minnesota
All sleep studies in Minnesota →- RecruitingHealthy volunteersOvernight stay mentioned
Circadian Rhythms in Human Adipose
Mayo Clinic
- Location
- Rochester, MN
- Eligibility basics
- Ages 18–55
- RecruitingPhase 3
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
Pfizer
- Location
- Maplewood, MN + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Eli Lilly and Company
- Location
- Maplewood, MN + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Alkermes, Inc.
- Location
- Rochester, MN + 21 other US sites
- Eligibility basics
- Ages 18–70